Shinde et al., 2023 - Google Patents
Therapeutic delivery of tumor suppressor miRNAs for breast cancer treatmentShinde et al., 2023
View HTML- Document ID
- 18045295933191036351
- Author
- Shinde S
- Ahmed S
- Malik J
- Hani U
- Khanam A
- Ashraf Bhat F
- Ahmad Mir S
- Ghazwani M
- Wahab S
- Haider N
- Almehizia A
- Publication year
- Publication venue
- Biology
External Links
Snippet
Simple Summary The most frequent cancer in women is breast cancer (BC), which presents a significant risk to their good health. Over the past few decades, several factors have significantly affected BC progression and treatment. Additionally, microRNAs (miRNAs) that …
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7088—Compounds having three or more nucleosides or nucleotides
- A61K31/713—Double-stranded nucleic acids or oligonucleotides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
- A61K9/5107—Excipients; Inactive ingredients
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/14—Type of nucleic acid interfering N.A.
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Reda El Sayed et al. | MicroRNA therapeutics in cancer: current advances and challenges | |
| Forterre et al. | A comprehensive review of cancer MicroRNA therapeutic delivery strategies | |
| Kong et al. | Intravesical delivery of KDM6A-mRNA via mucoadhesive nanoparticles inhibits the metastasis of bladder cancer | |
| Wang et al. | Nanomaterials for cancer precision medicine | |
| Hattinger et al. | Drug resistance in osteosarcoma: emerging biomarkers, therapeutic targets and treatment strategies | |
| Zaimy et al. | New methods in the diagnosis of cancer and gene therapy of cancer based on nanoparticles | |
| Desantis et al. | MicroRNAs-based nano-strategies as new therapeutic approach in multiple myeloma to overcome disease progression and drug resistance | |
| Gajda et al. | Combinatory treatment with miR-7-5p and drug-loaded cubosomes effectively impairs cancer cells | |
| Buocikova et al. | Epigenetics in breast cancer therapy—New strategies and future nanomedicine perspectives | |
| Romano et al. | microRNAs as novel therapeutics in cancer | |
| Shinde et al. | Therapeutic delivery of tumor suppressor miRNAs for breast cancer treatment | |
| Oh-Hohenhorst et al. | Role of metastasis-related microRNAs in prostate cancer progression and treatment | |
| Alsidawi et al. | MicroRNAs in brain metastases: potential role as diagnostics and therapeutics | |
| Fahmy et al. | Molecular engines, therapeutic targets, and challenges in pediatric brain tumors: a special emphasis on hydrogen sulfide and RNA-based nano-delivery | |
| Arrighetti et al. | miRNAs as therapeutic tools and biomarkers for prostate cancer | |
| Ambrosio et al. | Carbosilane dendrimers loaded with siRNA targeting Nrf2 as a tool to overcome cisplatin chemoresistance in bladder cancer cells | |
| Zhang et al. | The miRNA-21-5p payload in exosomes from M2 macrophages drives tumor cell aggression via PTEN/Akt signaling in renal cell carcinoma | |
| Wong et al. | Potential miRNAs for miRNA-based therapeutics in breast cancer | |
| Wei et al. | Aptamers as smart ligands for targeted drug delivery in cancer therapy | |
| Kara et al. | miRacle of microRNA-driven cancer nanotherapeutics | |
| Raguraman et al. | Drug delivery approaches for HuR-targeted therapy for lung cancer | |
| Kurtanich et al. | Pancreatic cancer gene therapy delivered by nanoparticles | |
| Sarvari et al. | Advances of epigenetic biomarkers and epigenome editing for early diagnosis in breast cancer | |
| Solé et al. | MicroRNAs and metastasis | |
| Li et al. | MicroRNA-34a, prostate cancer stem cells, and therapeutic development |